ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Aloe-Emodin Derivative, an Anthraquinone Compound, Attenuates Pyroptosis by Targeting NLRP3 Inflammasome in Diabetic Cardiomyopathy

Hu, Yingying; Zhang, Shuqian; Lou, Han; Mikaye, Monayo Seth; Xu, Run; Meng, Ziyu; Du, Menghan; Tang, Pingping; Chen, Zhouxiu; Chen, Yongchao; Liu, Xin; Du, Zhimin*; Zhang, Yong*哈尔滨医科大学; 中国医学科学院; y
Pharmaceuticals2023-9DOI: 10.3390/ph16091275
8阅读
引用收藏
分享

摘要

Diabetic cardiomyopathy (DCM) is widely recognized as a major contributing factor to the development of heart failure in patients with diabetes. Previous studies have demonstrated the potential benefits of traditional herbal medicine for alleviating the symptoms of cardiomyopathy. We have chemically designed and synthesized a novel compound called aloe-emodin derivative (AED), which belongs to the aloe-emodin (AE) family of compounds. AED was formed by covalent binding of monomethyl succinate to the anthraquinone mother nucleus of AE using chemical synthesis techniques. The purpose of this study was to investigate the effects and mechanisms of AED in treating DCM. We induced type 2 diabetes in Sprague-Dawley (SD) rats by administering a high-fat diet and streptozotocin (STZ) injections. The rats were randomly divided into six groups: control, DCM, AED low concentration (50 mg/kg/day), AED high concentration (100 mg/kg/day), AE (100 mg/kg/day), and positive control (glyburide, 2 mg/kg/day) groups. There were eight rats in each group. The rats that attained fasting blood glucose of >16.7 mmol/L were considered successful models. We observed significant improvements in cardiac function in the DCM rats with both AED and AE following four weeks of intragastric treatment. However, AED had a more pronounced therapeutic effect on DCM compared to AE. AED exhibited an inhibitory effect on the inflammatory response in the hearts of DCM rats and high-glucose-treated H9C2 cells by suppressing the pyroptosis pathway mediated by the nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain 3 (NLRP3) inflammasome. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of differentially expressed genes showed a significant enrichment in the NOD-like receptor signaling pathway compared to the high-glucose group. Furthermore, overexpression of NLRP3 effectively reversed the anti-pyroptosis effects of AED in high-glucose-treated H9C2 cells. This study is the first to demonstrate that AED possesses the ability to inhibit myocardial pyroptosis in DCM. Targeting the pyroptosis pathway mediated by the NLRP3 inflammasome could provide a promising therapeutic strategy to enhance our understanding and treatment of DCM.

学科与关键词

关键词
aloe-emodin derivativediabetic cardiomyopathypyroptosisNLRP3 inflammasome
相关
加载中…
  • Berberine inhibits NLRP3 inflammasome activation by regulating mTOR/ mtROS axis to alleviate diabetic cardiomyopathy
    Zhong, Changsheng; Xie, Yilin; Wang, Huifang; Chen, Wenxian; Yang, Zhenbo; Zhang, Lei; Deng, Qin; Cheng, Ting; Li, Mengyang; Ju, Jin; Liu, Yanyan*; Liang, Haihai*European Journal of Pharmacology, 2024, 964: 176253.
  • The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation
    Yan, Meiling; Li, Lun; Wang, Qing; Shao, Xiaoqi; Luo, Qingmao; Liu, Suping; Li, Yun; Wang, Dongwei; Zhang, Yue; Diao, Hongtao; Rong, Xianglu; Guo, Jiao*Biomedicine and Pharmacotherapy, 2022, 148: 112709.被引 12
  • NOX1 promotes myocardial fibrosis and cardiac dysfunction via activating the TLR2/NF-κB pathway in diabetic cardiomyopathy
    Zhang, Dandan; Li, Yilan; Wang, Weijie; Lang, Xueyan; Zhang, Yanxiu; Zhao, Qianqian; Yan, Jingru; Zhang, YaoFrontiers in Pharmacology, 2022, 13: 928762.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmaceuticals
发表日期
2023-09
卷期
第 16 卷, 第 9 期
页码
1275
DOI
10.3390/ph16091275
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82273919, 82270396]; HMU Marshal Initiative Funding [HMUMIF-21022]

作者

  • H

    Hu, Yingying (第一作者)

    harbin med univ

  • Z

    Zhang, Shuqian

    harbin med univ

查看全部 13 位作者收起作者
  • L

    Lou, Han

    harbin med univ

  • M

    Mikaye, Monayo Seth

    harbin med univ

  • X

    Xu, Run

    harbin med univ

  • M

    Meng, Ziyu

    harbin med univ

  • D

    Du, Menghan

    harbin med univ

  • T

    Tang, Pingping

    harbin med univ

  • C

    Chen, Zhouxiu

    harbin med univ

  • C

    Chen, Yongchao

    harbin med univ

  • L

    Liu, Xin

    harbin med univ · chinese acad med sci

  • D

    Du, Zhimin (通讯)

    2 · harbin med univ

  • Z

    Zhang, Yong (通讯)

    harbin med univ · chinese acad med sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417